Clinical Trial Results: Social Safety Learning in the Brain Oxytocin System [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results evaluating social safety learning in the brain oxytocin system for social phobia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Phobia

Snippet

Sponsor: University of Washington | Conditions: Social Phobia | Phase 2 | Status: COMPLETED | Results posted: 2026-06-11